Publication Date: 2018-11-07
Practice Area: Patent Litigation
Industry: Pharmaceuticals
Court: U.S. District Court of Delaware
Judge: District Judge Stark
Attorneys: For plaintiff: Joseph J. Farnan, Brian E. Farnan, Michael J. Farnan, Farnan LLP, Wilmington, DE; Amy K. Wigmore, Gregory H. Lantiere, Heather M. Petruzzi, Tracey C. Allen, Jeffrey T. Hanston, Wilmer Cutler Pickering Hale & Dale LLP, Washington, DC; Kevin S. Prussia, Andrew J. Danford, Timothy A. Cook, Kevin M. Yukerwich, Wilmer Cutler Pickering Hale & Dale LLP, Boston, MA, attorneys for plaintiffs
for defendant: Arthur G. Connolly, III, Connolly Gallagher LLP, Wilmington, DE; Neal C. Belgam, Eve H. Ormerod, Smith, Katzenstein & Jenkins LLP, Wilmington, DE; Stamatios Stamaulis, Richard C. Weinblatt, Stamoulis & Weinblatt LLC, Wilmington, DE; Karen L. Pascale, Robert M. Vrana, Young Conaway Stargatt & Taylor LLP, Wilmington, DE; John C. Phillips, Jr., David A. Bilson, Phillips, Goldman, McLaughlin & Hall, P.A., Wilmington, DE; David Ellis Moore, Bindu Palapura, Stephanie E. O'Byrne, Potter Anderson & Corroon, LLP, Wilmington, DE; Sean M. Brennecke, Klehr Harrison Harvey Branzburg LLP, Wilmington, DE; Dominick T. Gattuso, Heyman Enerio Gattuso & Hirzel LLP, Wilmington, DE, attorneys for defendants.
Case Number: D68342
Court rejected more restrictive construction of patent claims where intrinsic evidence indicated that patentee did not intend to apply different definitions when using term in different applications or to restrict measurement techniques to meet patent specification for active particles.